Tecadenoson

CAS : 204512-90-3

Ref. 3D-EIA51290

Informations sur le produit

• Nom: Tecadenoson
• Synonymes: (2R,3R,4S,5R)-2-(Hydroxymethyl)-5-[6-[tetrahydrofuran-3(R)-ylamino]-9H-purin-9-yl]tetrahydrofuran-3,4-diol, Adenosine, N-[(3R)-tetrahydro-3-furanyl]-, Cvt-510, N-[(3R)-Tetrahydro-3-furanyl]adenosine, N-[(3R)-tetrahydrofuran-3-yl]adenosine

Description

Tecadenoson is an analog of adenosine. It has been shown to have synergistic effects in treating congestive heart failure and inflammatory bowel disease due to its ability to act on receptors. Tecadenoson has also been shown to increase blood flow in the bowel, which can be used for the treatment of bowel diseases such as Crohn's disease. Tecadenoson works by activating two types of receptors: A1 and A2A. Activation of these receptors leads to increased blood supply, which improves symptoms in patients with chronic obstructive pulmonary disease. Tecadenoson has also been shown to reduce inflammation and improve lung function in animal models of asthma. Tecadenoson is not active against bacterial infections or viral infections, but is effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and vasculitis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 337.33 g/mol
• Formule: C₁₄H₁₉N₅O₅
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder